Tracking “non-content” metadata is an important part of any pharmaceutical submission, yet many drugmakers fail to take an integrated approach to the task according to regulatory expert Kate Wilber.
Xcelience and IriSys have formed a joint venture to help streamline access to chemistry manufacturing and controls (CMC) and regulatory expertise for North American pharmaceutical and biotechnology companies.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PPD, Coldstream Laboratories and MPI Research.
ZRG Partners says there was a “fight for talent” in hiring, firing and vacancies in Q2, with the outsourcing and pharmaceutical sectors battling for employees within regulatory, quality and clinical roles.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Discovery Labs, NewAge Industries and Jennerex.
Parexel has collaborated with Stora Enso to add an integrated temperature recording system which can save up to 48 hours compared to traditional cold chain.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including J&J strengthening manufacturing and appointments at Alexza and Inspire.
Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.
Imclone has closed the manufacturing facility in Branchburg, New Jersey where it produces the cancer drug Erbitux, according to reports in the US media.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Quintiles, WuXi, NeoGenomics and BASi.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Ranbaxy’s CEO stepping down and appointments at Avid, the USP and Novavax.
Furiex posts Q2 loss as increased R&D spending and higher admin costs offset revenue gains, but firm is confident development model can boost partners’ pipelines.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Kendle, Invida and Global Research Services (GRS).
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Watson Pharmaceuticals, Shire, Lupin and AmerisourceBergen.
World Courier is continuing its period of rapid expansion by breaking ground on a 135,000 sq ft clinical trial storage and distribution centre in Singapore.
In the first of a series of special in-pharmatechnologist podcasts Kate Wilber, Image Solutions’ (ISI) director of regulatory Services, Europe discusses the emerging trends in BPO and talks about how it can benefit drugmakers.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Roche, Caraco, CMP Therapeutics and Unilife.
Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact on contract research organizations (CRO).
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Phage Pharmaceuticals, the USP and Nycomed.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, ACR Image Metrix and Health Decisions.
While the summer* heat may slow other industries, the outsourcing sector keeps on moving. Oustourcing-pharma rounds up the key developments, featuring LyoTechnica and AspenTech
A group of Irish drug firms and banks plan to set up a “global pharmaceutical centre of excellence” (COE) that they believe will create 4,800 research, development and manufacturing jobs.
GSK and Pfizer’s ViiV Healthcare JV says it will make its entire drug portfolio available to generics manufacturers and 80 per cent the global HIV-infected population.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new leader at PhRMA and KV replacing its CFO after three months in the job.
M&A can help revitalize firms but failure to properly integrate the companies can create an inefficient, demoralized business. In this article, Viq Pervaaz, senior vice president at Aon Consulting, takes a look at M&A processes, pitfalls and keys...
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Almac, BioStorage Technologies and ACM Global.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at GSK, KV Pharmaceutical, ParagonRx, West, Novavax and Unilife.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments West Pharmaceutical Services, Unilife and ACR Image Metrix.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Elan, Inspire Pharmaceuticals, BioVex and Lux Biosciences.
Rumour has it that French drug giant Sanofi Aventis is planning to make a $20bn (€16bn) acquisition in the US with speculation that biotechs like Allergan, Biogen Idec and Genzyme are among the targets.
Abbott Laboratories has confirmed it is considering the sale of the vaccines unit it gained with the €4.5bn ($6.2bn) acquisition of Solvay Pharmaceuticals in February.
India’s oldest pharmaceutical company Alembic went one step closer to the biggest restructuring in its history as its board approved the demerging of its main pharmaceutical business into a separate subsidiary company, Alembic Pharma.
Sanofi-Aventis will build a new manufacturing plant in King Abdullah Economic City (KAEC) in Saudi Arabia through an agreement with the Emaar development company (ECC).
A deal to broaden Gilead’s research expertise into protein kinase biology has been finalised with the $120m acquisition of CGI Pharmaceuticals, in a deal that compliments its comprehensive selection of anti-HIV treatments.
Regulus Therapeutics’ microRNA satellite technology has won the firm its biggest deal to date with French drugmaker Sanofi-Aventis agreeing a development accord worth up to $750m (€606m).
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing space, including appointments at DPT, PPD, ACR Image Metrix, NexMed, ResearchPoint, CEDRA, Chemspec and Covance.
